ALTAVANT

Pharmaceutical preparations for human use for the treatment of pulmonary arterial hypertension, pulmonary fibrosis, sarcoidosis, and respiratory diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of pulmonary arterial hypertension, pulmonary fibrosis, sarcoidosis, and respiratory diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials

Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions